- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patent holdings for IPC class A61P 31/00
Total number of patents in this class: 6418
10-year publication summary
|
259
|
281
|
245
|
351
|
496
|
426
|
516
|
464
|
415
|
83
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
275 |
| Bristol-myers Squibb Company | 5080 |
65 |
| The Regents of the University of California | 18943 |
41 |
| Merck Patent GmbH | 5909 |
32 |
| Centre National de La Recherche Scientifique | 9632 |
28 |
| Novartis AG | 11238 |
27 |
| Agency for Science, Technology and Research | 3512 |
25 |
| Takeda Pharmaceutical Company Limited | 2961 |
25 |
| Pfizer Inc. | 3322 |
23 |
| The Johns Hopkins University | 5377 |
22 |
| The General Hospital Corporation | 4517 |
22 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
22 |
| F. Hoffmann-La Roche AG | 7958 |
21 |
| President and Fellows of Harvard College | 5792 |
20 |
| AstraZeneca AB | 3042 |
19 |
| Daiichi Sankyo Company, Limited | 1829 |
19 |
| Merck Sharp & Dohme Corp. | 2247 |
18 |
| Incyte Corporation | 918 |
18 |
| Merck Sharp & Dohme LLC | 3689 |
18 |
| Vertex Pharmaceuticals Incorporated | 1581 |
17 |
| Other owners | 5661 |